Withania Somnifera, Indian Ginseng, Ashwagandha

Ashwagandha is a plant used in Ayurvedic medicine, the traditional Indian medicine. Several parts of the plant are used, but the most common in supplements is an extract from its roots. Ashwagandha is classified as an adaptogen, meaning it can help your body manage stress.

  • Origin: Plant Based
  • Source: Itself
  • Type: Herbs, Roots & Barks
  • Age Range: Adults
  • Toxicity: May be toxic in high doses
  • Outcomes: Cognitive Function and Brain Health, Energy and Mood, Muscle Health, Specific Conditions, Memory Enhancer, Anxiety, Sleep Quality, Power Output, Blood Sugar Control

What are Ashwagandha benefits?

Ashwagandha ( Withania somnifera ) is an herb popularly used in Ayurvedic medicine, the traditional medicine of India. Its root has a horse smell (in Sanskrit, ashva means ‘horse’ and gandha means ‘smell’) and is said to impart the strength and virility of a horse. Several parts of the plant are used, but the most common in supplements is an extract of its roots. Several studies suggest that Ashwagandha has anxiolytic (anti-anxiety) effects, and appears to reduce cortisol levels. It may also be able to reduce insomnia, fatigue, and symptoms of depression. May increase intensity during endurance exercise and anaerobic running. It may lead to small reductions in blood glucose, blood pressure, and LDL cholesterol, while slightly increasing HDL cholesterol. In addition, it may modestly increase testosterone and sperm quality in infertile men. Check out the quiz and find out which areas Ashwagandha can help you with!

Table of relations

Consistent effects
Strength of effects
Scientific articles

Cognitive Function and Brain Health Ashwagandha and Cognitive Function and Brain Health

Cognitive functions are brain skills divided into: memory, perception, language, executive functions, attention and praxis (ability to perform complex movements). These functions depend on healthy synapses and neurons, which require good overall brain functioning. Supplements can affect cognitive performance directly or indirectly. Direct effects can alter or participate in neurotransmissions and influence the brain's energy metabolism. The indirect effects include hormonal changes that affect the brain, and improvements in cognitive disorders such as anxiety, depression and insomnia.
  • Memory Enhancer

    Memory lapses are common, after all, who has never forgotten a name or address? In an age of information bombardment, our brain filters what is or is not important to be stored. With these filters, we have the long and short-term memory, in which our brain divides what will be used frequently and what will not be recurrent, like a computer HD. The first happens to many people and is about forgetting common information such as telephone numbers, while the second reflects the loss of memory of moments in life or names of children. However, for these lapses not to become frequent it is important that there is a preventive care with the memory, thus it is possible to avoid greater damage to the cognitive health of this area.

Energy and Mood Ashwagandha and Energy and Mood

Energy and mood are associated with several external and internal factors. Hormone release, brain chemical balance, nutrient metabolism, and several other elements alter the way the body and mind respond to daily activities. The compounds that benefit energy and mood are the ones that help in the balance of all these factors.
  • Anxiety

    Anxiety is the body's natural response to stress. It's a feeling of fear or apprehension about what's to come. It can be triggered by a specific situation and not last long - which is very common and ok - or it can be a generalized disorder (which is considered a illness) that can bring harm to everyday life and also cause other conditions like depression.

  • Sleep Quality

    Sleep is a very important physiological process, as it regulates the body's functions. It is responsible for promoting / facilitating energy conservation, synthesis and secretion of hormones and proteins, learning and memory through brain changes. Sleep is mainly driven by the circadian cycle, which involves exposure to light, hormones such as melatonin, and hypothalamic activity. The compounds that help regulate sleep work in different pathways, they can facilitate the process of falling asleep, increase the duration of continuous sleep or improve the quality of sleep.

Muscle Health Ashwagandha and Muscle Health

The muscles are responsible for body movement, stabilization, regulation of organs, substance transportation and production of heat in addition to being strongly associated with the circulatory and nervous systems. Muscle quality is essential for well being. Supplements that help keep muscles healthy are related to different factors, such as glucose and insulin regulation, protein synthesis, energy metabolism, and others.
  • Power Output

    Power output is the strength the body can develop in the shortest amount of time. It have to do with muscle fibers, creatine stores and ATP.

Specific Conditions Ashwagandha and Specific Conditions

Specific body conditions categorize precise areas of our body, such as: Respiratory allergies; Liver; Eye health; Blood pressure; Cholesterol and triglycerides; and Blood glucose control. These areas require specific attention because they are delicate functions related to other parts of the body. Respiratory allergies, for example, are linked to the immune system, and to present an effective nutraceutical, we keep our scientific base up to date.
  • Blood Sugar Control

    The body's cells use glucose to produce energy. Glucose comes from food and is stored in the body in the form of glycogen (in the muscles and liver) or circulating glucose (in the blood). Cells need the hormone Insulin to capture glucose molecules. The glucose / insulin balance in the blood is essential for the proper functioning of the body's whole metabolism. A change in this metabolism can lead to serious physiological dysfunctions, leading to the development of chronic non-communicable diseases, such as type II diabetes and cardiovascular diseases. There are several classes of compounds that influence this metabolism, these can increase insulin synthesis and secretion, decrease blood glucose levels, reduce the immediate absorption of carbohydrates, regulate the sensitivity of cells to insulin, among others.

Related videos about Ashwagandha


  1. ^ Modi MB, Donga SB, Dei L. Clinical evaluation of Ashokarishta, Ashwagandha Churna and Praval Pishti in the management of menopausal syndromeAyu. (2012)
  2. ^ Mahanta V, Dudhamal TS, Gupta SK. Management of tennis elbow by AgnikarmaJ Ayurveda Integr Med. (2013)
  3. a b Vyas P, et al. Clinical evaluation of Rasayana compound as an adjuvant in the management of tuberculosis with anti-Koch’s treatmentAyu. (2012)
  4. a b Chopra A, et al. A 32-week randomized, placebo-controlled clinical evaluation of RA-11, an Ayurvedic drug, on osteoarthritis of the kneesJ Clin Rheumatol. (2004)
  5. a b c d e f Widodo N, et al. Selective killing of cancer cells by Ashwagandha leaf extract and its component Withanone involves ROS signalingPLoS One. (2010)
  6. ^ Widodo N, et al. Selective killing of cancer cells by leaf extract of Ashwagandha: components, activity and pathway analysesCancer Lett. (2008)
  7. ^ Dhuley JN. Adaptogenic and cardioprotective action of ashwagandha in rats and frogsJ Ethnopharmacol. (2000)
  8. ^ Kulkarni SK, Dhir A. Withania somnifera: an Indian ginsengProg Neuropsychopharmacol Biol Psychiatry. (2008)
  9. ^ Baliga MS, et al. Rasayana Drugs From the Ayurvedic System of Medicine as Possible Radioprotective Agents in Cancer TreatmentIntegr Cancer Ther. (2013)
  10. a b c d e Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adultsIndian J Psychol Med. (2012)
  11. ^ Deocaris CC, et al. Merger of ayurveda and tissue culture-based functional genomics: inspirations from systems biologyJ Transl Med. (2008)
  12. ^ Modak M, et al. Indian herbs and herbal drugs used for the treatment of diabetesJ Clin Biochem Nutr. (2007)
  13. a b [No authors listed. Monograph. Withania somniferaAltern Med Rev. (2004)
  14. a b c d e f g h i j k l m n o p q r s t u Chatterjee S, et al. Comprehensive metabolic fingerprinting of Withania somnifera leaf and root extractsPhytochemistry. (2010)
  15. a b Namdeo AG, et al. Metabolic characterization of Withania somnifera from different regions of India using NMR spectroscopyPlanta Med. (2011)
  16. a b c Zhao J, et al. Withanolide derivatives from the roots of Withania somnifera and their neurite outgrowth activitiesChem Pharm Bull (Tokyo). (2002)
  17. a b c d Choudhary MI, et al. Chlorinated and diepoxy withanolides from Withania somnifera and their cytotoxic effects against human lung cancer cell linePhytochemistry. (2010)
  18. ^ Tong X, Zhang H, Timmermann BN. Chlorinated Withanolides from Withania somniferaPhytochem Lett. (2011)
  19. ^ Pramanick S, et al. Withanolide Z, a new chlorinated withanolide from Withania somniferaPlanta Med. (2008)
  20. a b Bhattacharya SK, Satyan KS, Ghosal S. Antioxidant activity of glycowithanolides from Withania somniferaIndian J Exp Biol. (1997)
  21. a b c Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a reviewAltern Med Rev. (2000)
  22. a b Ganzera M, Choudhary MI, Khan IA. Quantitative HPLC analysis of withanolides in Withania somniferaFitoterapia. (2003)
  23. a b c d e f Subbaraju GV, et al. Ashwagandhanolide, a bioactive dimeric thiowithanolide isolated from the roots of Withania somniferaJ Nat Prod. (2006)
  24. a b c d e f Mulabagal V, et al. Withanolide sulfoxide from Aswagandha roots inhibits nuclear transcription factor-kappa-B, cyclooxygenase and tumor cell proliferationPhytother Res. (2009)
  25. ^ Misra L, et al. Unusually sulfated and oxygenated steroids from Withania somniferaPhytochemistry. (2005)
  26. a b c d e f g Alam N, et al. High catechin concentrations detected in Withania somnifera (ashwagandha) by high performance liquid chromatography analysisBMC Complement Altern Med. (2011)
  27. ^ Misra L, et al. 1,4-Dioxane and ergosterol derivatives from Withania somnifera rootsJ Asian Nat Prod Res. (2012)
  28. ^ Withanolides from Withania somnifera roots.
  29. a b Nosalova G, et al. Herbal polysaccharides and cough reflexRespir Physiol Neurobiol. (2013)
  30. a b Sinha S, et al. In vivo anti-tussive activity and structural features of a polysaccharide fraction from water extracted Withania somniferaJ Ethnopharmacol. (2011)
  31. ^ Girish KS, et al. Antimicrobial properties of a non-toxic glycoprotein (WSG) from Withania somnifera (Ashwagandha)J Basic Microbiol. (2006)
  32. ^ Machiah DK, Girish KS, Gowda TV. A glycoprotein from a folk medicinal plant, Withania somnifera, inhibits hyaluronidase activity of snake venomsComp Biochem Physiol C Toxicol Pharmacol. (2006)
  33. ^ Chen LX, He H, Qiu F. Natural withanolides: an overviewNat Prod Rep. (2011)
  34. a b c d e f Udayakumar R, et al. Hypoglycaemic and hypolipidaemic effects of Withania somnifera root and leaf extracts on alloxan-induced diabetic ratsInt J Mol Sci. (2009)
  35. ^ Phytochemical variability in commercial herbal products and preparations of Withania somnifera (Ashwagandha).
  36. ^ Srivastava P, et al. Simultaneous quantification of withanolides in Withania somnifera by a validated high-performance thin-layer chromatographic methodJ AOAC Int. (2008)
  37. a b c d e f g h Malik F, et al. A standardized root extract of Withania somnifera and its major constituent withanolide-A elicit humoral and cell-mediated immune responses by up regulation of Th1-dominant polarization in BALB/c miceLife Sci. (2007)
  38. a b c d e f g h i Yang Z, et al. Withania somnifera Root Extract Inhibits Mammary Cancer Metastasis and Epithelial to Mesenchymal TransitionPLoS One. (2013)
  39. ^ Shreevathsa M, Ravishankar B, Dwivedi R. Anti depressant activity of Mamsyadi Kwatha: An Ayurvedic compound formulationAyu. (2013)
  40. a b Yokota Y, et al. Development of withaferin A analogs as probes of angiogenesisBioorg Med Chem Lett. (2006)
  41. a b c d e f Bargagna-Mohan P, et al. The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentinChem Biol. (2007)
  42. ^ van Beijnum JR, et al. Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculatureBlood. (2006)
  43. ^ Eckes B, et al. Impaired wound healing in embryonic and adult mice lacking vimentinJ Cell Sci. (2000)
  44. a b c d e f Grin B, et al. Withaferin a alters intermediate filament organization, cell shape and behaviorPLoS One. (2012)
  45. ^ Rogers KR, Herrmann H, Franke WW. Characterization of disulfide crosslink formation of human vimentin at the dimer, tetramer, and intermediate filament levelsJ Struct Biol. (1996)
  46. a b c d e Thaiparambil JT, et al. Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylationInt J Cancer. (2011)
  47. ^ Li QF, et al. Critical role of vimentin phosphorylation at Ser-56 by p21-activated kinase in vimentin cytoskeleton signalingJ Biol Chem. (2006)
  48. a b c Lahat G, et al. Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studiesPLoS One. (2010)
  49. ^ Karin M, Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signallingSemin Immunol. (2000)
  50. ^ Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzleCell. (2002)
  51. a b c Grover A, et al. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera’s key metabolite withaferin ABMC Genomics. (2010)
  52. a b Rushe M, et al. Structure of a NEMO/IKK-associating domain reveals architecture of the interaction siteStructure. (2008)
  53. a b Kaileh M, et al. Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activityJ Biol Chem. (2007)
  54. ^ Na HK, Surh YJ. Transcriptional regulation via cysteine thiol modification: a novel molecular strategy for chemoprevention and cytoprotectionMol Carcinog. (2006)
  55. a b c d e Yang H, Shi G, Dou QP. The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from “Indian winter cherry”Mol Pharmacol. (2007)
  56. ^ Yang H, et al. Celastrol, a triterpene extracted from the Chinese “Thunder of God Vine,” is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude miceCancer Res. (2006)
  57. ^ Grover A, et al. Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomesBMC Genomics. (2010)
  58. a b c d e f g h i j k Khedgikar V, et al. Withaferin A: a proteasomal inhibitor promotes healing after injury and exerts anabolic effect on osteoporotic boneCell Death Dis. (2013)
  59. ^ Liu J, et al. Impairment of the ubiquitin-proteasome system in desminopathy mouse heartsFASEB J. (2006)
  60. a b Yang H, et al. Withaferin A inhibits the proteasome activity in mesothelioma in vitro and in vivoPLoS One. (2012)
  61. ^ Rishi AK, et al. Cell cycle- and apoptosis-regulatory protein-1 is involved in apoptosis signaling by epidermal growth factor receptorJ Biol Chem. (2006)
  62. ^ Wadegaonkar VP, Wadegaonkar PA. Withanone as an inhibitor of survivin: A potential drug candidate for cancer therapyJ Biotechnol. (2013)
  63. ^ Kaul SC, Deocaris CC, Wadhwa R. Three faces of mortalin: a housekeeper, guardian and killerExp Gerontol. (2007)
  64. ^ Dundas SR, et al. Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survivalJ Pathol. (2005)
  65. a b Wadhwa R, et al. Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesisInt J Cancer. (2006)
  66. ^ Wadhwa R, et al. Hsp70 family member, mot-2/mthsp70/GRP75, binds to the cytoplasmic sequestration domain of the p53 proteinExp Cell Res. (2002)
  67. ^ Kaula SC, et al. Inactivation of p53 and life span extension of human diploid fibroblasts by mot-2FEBS Lett. (2000)
  68. a b Grover A, et al. Withanone binds to mortalin and abrogates mortalin-p53 complex: computational and experimental evidenceInt J Biochem Cell Biol. (2012)
  69. ^ Wadhwa R, et al. Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 functionCancer Res. (2000)
  70. ^ Eyers PA, et al. A novel mechanism for activation of the protein kinase Aurora ACurr Biol. (2003)
  71. ^ Tsai MY, et al. A Ran signalling pathway mediated by the mitotic kinase Aurora A in spindle assemblyNat Cell Biol. (2003)
  72. ^ Bischoff JR, et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancersEMBO J. (1998)
  73. ^ Bar-Shira A, et al. Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograftCancer Res. (2002)
  74. ^ Li D, et al. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancerClin Cancer Res. (2003)
  75. ^ Tanaka T, et al. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breastCancer Res. (1999)
  76. ^ Agnese V, et al. The role of Aurora-A inhibitors in cancer therapyAnn Oncol. (2007)
  77. ^ Warner SL, et al. Validation of TPX2 as a potential therapeutic target in pancreatic cancer cellsClin Cancer Res. (2009)
  78. a b c Grover A, et al. Ashwagandha derived withanone targets TPX2-Aurora A complex: computational and experimental evidence to its anticancer activityPLoS One. (2012)
  79. ^ Zhao B, et al. Modulation of kinase-inhibitor interactions by auxiliary protein binding: crystallography studies on Aurora A interactions with VX-680 and with TPX2Protein Sci. (2008)
  80. a b Grover A, et al. Blocking protein kinase C signaling pathway: mechanistic insights into the anti-leishmanial activity of prospective herbal drugs from Withania somniferaBMC Genomics. (2012)
  81. a b c Nakajima H, et al. An Extract of Withania somnifera Attenuates Endothelin-1-stimulated Pigmentation in Human Epidermal Equivalents through the Interruption of PKC Activity Within MelanocytesPhytother Res. (2012)
  82. ^ Hartl FU. Molecular chaperones in cellular protein foldingNature. (1996)
  83. ^ Young JC, et al. Pathways of chaperone-mediated protein folding in the cytosolNat Rev Mol Cell Biol. (2004)
  84. ^ Welch WJ. Heat shock proteins functioning as molecular chaperones: their roles in normal and stressed cellsPhilos Trans R Soc Lond B Biol Sci. (1993)
  85. ^ Kamal A, Boehm MF, Burrows FJ. Therapeutic and diagnostic implications of Hsp90 activationTrends Mol Med. (2004)
  86. ^ Pearl LH, Prodromou C, Workman P. The Hsp90 molecular chaperone: an open and shut case for treatmentBiochem J. (2008)
  87. ^ Solit DB, Chiosis G. Development and application of Hsp90 inhibitorsDrug Discov Today. (2008)
  88. ^ Powers MV, Workman P. Inhibitors of the heat shock response: biology and pharmacologyFEBS Lett. (2007)
  89. ^ Neckers L. Development of small molecule Hsp90 inhibitors: utilizing both forward and reverse chemical genomics for drug identificationCurr Med Chem. (2003)
  90. ^ Gray PJ Jr, et al. Targeting the oncogene and kinome chaperone CDC37Nat Rev Cancer. (2008)
  91. a b c Yu Y, et al. Withaferin A targets heat shock protein 90 in pancreatic cancer cellsBiochem Pharmacol. (2010)
  92. a b c Grover A, et al. Hsp90/Cdc37 chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin ABMC Bioinformatics. (2011)
  93. a b Patil D, et al. Determination of withaferin A and withanolide A in mice plasma using high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics after oral administration of Withania somnifera aqueous extractJ Pharm Biomed Anal. (2013)
  94. a b Bharavi K, et al. Prevention of cadmium bioaccumulation by herbal adaptogensIndian J Pharmacol. (2011)
  95. ^ Bharavi K, et al. Reversal of Cadmium-induced Oxidative Stress in Chicken by Herbal Adaptogens Withania Somnifera and Ocimum SanctumToxicol Int. (2010)
  96. ^ Sharma V, Sharma S, Pracheta. Protective effect of Withania somnifera roots extract on hematoserological profiles against lead nitrate-induced toxicity in miceIndian J Biochem Biophys. (2012)
  97. ^ Otterbein LE, et al. Heme oxygenase-1 and carbon monoxide modulate DNA repair through ataxia-telangiectasia mutated (ATM) proteinProc Natl Acad Sci U S A. (2011)
  98. ^ Motterlini R, et al. Endothelial heme oxygenase-1 induction by hypoxia. Modulation by inducible nitric-oxide synthase and S-nitrosothiolsJ Biol Chem. (2000)
  99. a b c d e Hosny Mansour H, Farouk Hafez H. Protective effect of Withania somnifera against radiation-induced hepatotoxicity in ratsEcotoxicol Environ Saf. (2012)
  100. a b Velmurugan K, et al. Synergistic induction of heme oxygenase-1 by the components of the antioxidant supplement ProtandimFree Radic Biol Med. (2009)
  101. a b c d e f g Widodo N, et al. Deceleration of senescence in normal human fibroblasts by withanone extracted from ashwagandha leavesJ Gerontol A Biol Sci Med Sci. (2009)
  102. ^ Widodo N, et al. Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effectClin Cancer Res. (2007)
  103. ^ p21Waf1/Cip1 Plays a Critical Role in Modulating Senescence Through Changes of DNA Methylation.
  104. a b c d e Bhattacharya SK, et al. Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental studyPhytomedicine. (2000)
  105. ^ Grover A, et al. Computational evidence to inhibition of human acetyl cholinesterase by withanolide a for Alzheimer treatmentJ Biomol Struct Dyn. (2012)
  106. ^ Choudhary MI, et al. Cholinesterase inhibiting withanolides from Withania somniferaChem Pharm Bull (Tokyo). (2004)
  107. a b c Schliebs R, et al. Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brainNeurochem Int. (1997)
  108. a b Seth V, et al. Lipid peroxidation, antioxidant enzymes, and glutathione redox system in blood of human poisoning with propoxurClin Biochem. (2000)
  109. a b Yadav CS, et al. Propoxur-induced acetylcholine esterase inhibition and impairment of cognitive function: attenuation by Withania somniferaIndian J Biochem Biophys. (2010)
  110. ^ Bhattarai JP, Park SJ, Han SK. Potentiation of NMDA Receptors by Withania somnifera on Hippocampal CA1 Pyramidal NeuronsAm J Chin Med. (2013)
  111. ^ Soman S, et al. Impaired motor learning attributed to altered AMPA receptor function in the cerebellum of rats with temporal lobe epilepsy: Ameliorating effects of Withania somnifera and withanolide AEpilepsy Behav. (2013)
  112. a b Soman S, et al. Oxidative stress induced NMDA receptor alteration leads to spatial memory deficits in temporal lobe epilepsy: ameliorative effects of Withania somnifera and Withanolide ANeurochem Res. (2012)
  113. ^ Singh J, Kaur G. Transcriptional regulation of PSA-NCAM expression by NMDA receptor activation in RA-differentiated C6 glioma culturesBrain Res Bull. (2009)
  114. ^ Rabinovsky ED, Le WD, McManaman JL. Differential effects of neurotrophic factors on neurotransmitter development in the IMR-32 human neuroblastoma cell lineJ Neurosci. (1992)
  115. a b Kataria H, et al. Water extract from the leaves of Withania somnifera protect RA differentiated C6 and IMR-32 cells against glutamate-induced excitotoxicityPLoS One. (2012)
  116. ^ Parihar MS, Hemnani T. Phenolic antioxidants attenuate hippocampal neuronal cell damage against kainic acid induced excitotoxicityJ Biosci. (2003)
  117. ^ Han SK, Abraham IM, Herbison AE. Effect of GABA on GnRH neurons switches from depolarization to hyperpolarization at puberty in the female mouseEndocrinology. (2002)
  118. ^ DeFazio RA, et al. Activation of A-type gamma-aminobutyric acid receptors excites gonadotropin-releasing hormone neuronsMol Endocrinol. (2002)
  119. a b c Kumar A, Kalonia H. Effect of Withania somnifera on Sleep-Wake Cycle in Sleep-Disturbed Rats: Possible GABAergic MechanismIndian J Pharm Sci. (2008)
  120. a b Mehta AK, et al. Pharmacological effects of Withania somnifera root extract on GABAA receptor complexIndian J Med Res. (1991)
  121. ^ Kulkarni SK, Akula KK, Dhir A. Effect of Withania somnifera Dunal root extract against pentylenetetrazol seizure threshold in mice: possible involvement of GABAergic systemIndian J Exp Biol. (2008)
  122. ^ Bhattarai JP, Ah Park S, Han SK. The methanolic extract of Withania somnifera ACTS on GABAA receptors in gonadotropin releasing hormone (GnRH) neurons in micePhytother Res. (2010)
  123. a b c Ahmad M, et al. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in ratsHum Exp Toxicol. (2005)
  124. a b c d e Shah PC, et al. Effect of Withania somnifera on forced swimming test induced immobility in mice and its interaction with various drugsIndian J Physiol Pharmacol. (2006)
  125. ^ Dhir A, Kulkarni SK. Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim testPharmacology. (2007)
  126. a b c Tripathi AK, et al. Alterations in the sensitivity of 5(th) receptor subtypes following chronic asvagandha treatment in ratsAnc Sci Life. (1998)
  127. a b c Ramanathan M, Balaji B, Justin A. Behavioural and neurochemical evaluation of Perment an herbal formulation in chronic unpredictable mild stress induced depressive modelIndian J Exp Biol. (2011)
  128. a b c d e Bhatnagar M, Sharma D, Salvi M. Neuroprotective effects of Withania somnifera dunal.: A possible mechanismNeurochem Res. (2009)
  129. ^ Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brainNature. (1988)
  130. ^ Dawson VL, et al. Nitric oxide mediates glutamate neurotoxicity in primary cortical culturesProc Natl Acad Sci U S A. (1991)
  131. ^ Harvey BH, et al. Increased hippocampal nitric oxide synthase activity and stress responsiveness after imipramine discontinuation: role of 5HT 2A/C-receptorsMetab Brain Dis. (2006)
  132. ^ Bhattacharya A, Ghosal S, Bhattacharya SK. Anti-oxidant effect of Withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatumJ Ethnopharmacol. (2001)
  133. ^ Chaurasia SS, Panda S, Kar A. Withania somnifera root extract in the regulation of lead-induced oxidative damage in male mousePharmacol Res. (2000)
  134. a b Baitharu I, et al. Withania somnifera root extract ameliorates hypobaric hypoxia induced memory impairment in ratsJ Ethnopharmacol. (2013)
  135. a b Naidu PS, Singh A, Kulkarni SK. Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunctionPhytother Res. (2006)
  136. a b Naidu PS, Singh A, Kulkarni SK. Effect of Withania somnifera root extract on haloperidol-induced orofacial dyskinesia: possible mechanisms of actionJ Med Food. (2003)
  137. a b Kasture S, et al. Withania somnifera prevents morphine withdrawal-induced decrease in spine density in nucleus accumbens shell of rats: a confocal laser scanning microscopy studyNeurotox Res. (2009)
  138. ^ Spiga S, et al. Morphine withdrawal-induced morphological changes in the nucleus accumbensEur J Neurosci. (2005)
  139. a b Priyandoko D, et al. Ashwagandha leaf derived withanone protects normal human cells against the toxicity of methoxyacetic acid, a major industrial metabolitePLoS One. (2011)
  140. ^ Tohda C, Kuboyama T, Komatsu K. Search for natural products related to regeneration of the neuronal networkNeurosignals. (2005)
  141. ^ Kuboyama T, et al. Axon- or dendrite-predominant outgrowth induced by constituents from AshwagandhaNeuroreport. (2002)
  142. a b Kuboyama T, Tohda C, Komatsu K. Neuritic regeneration and synaptic reconstruction induced by withanolide ABr J Pharmacol. (2005)
  143. ^ Jana CK, et al. Synthesis of withanolide A, biological evaluation of its neuritogenic properties, and studies on secretase inhibitionAngew Chem Int Ed Engl. (2011)
  144. ^ Tohda C, Kuboyama T, Komatsu K. Dendrite extension by methanol extract of Ashwagandha (roots of Withania somnifera) in SK-N-SH cellsNeuroreport. (2000)
  145. a b c d e f Tohda C, Joyashiki E. Sominone enhances neurite outgrowth and spatial memory mediated by the neurotrophic factor receptor, RETBr J Pharmacol. (2009)
  146. a b c Kuboyama T, Tohda C, Komatsu K. Withanoside IV and its active metabolite, sominone, attenuate Abeta(25-35)-induced neurodegenerationEur J Neurosci. (2006)
  147. a b Withanoside IV and its active metabolite, sominone, attenuate Aβ(25–35)-induced neurodegeneration.
  148. a b c d Konar A, et al. Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cellsPLoS One. (2011)
  149. ^ Durbec P, et al. GDNF signalling through the Ret receptor tyrosine kinaseNature. (1996)
  150. ^ Trupp M, et al. Functional receptor for GDNF encoded by the c-ret proto-oncogeneNature. (1996)
  151. a b Chaudhary G, et al. Evaluation of Withania somnifera in a middle cerebral artery occlusion model of stroke in ratsClin Exp Pharmacol Physiol. (2003)
  152. a b c Singh B, et al. Adaptogenic activity of a novel, withanolide-free aqueous fraction from the roots of Withania somnifera DunPhytother Res. (2001)
  153. a b Singh B, Chandan BK, Gupta DK. Adaptogenic activity of a novel withanolide-free aqueous fraction from the roots of Withania somnifera Dun. (Part II)Phytother Res. (2003)
  154. a b Kaur P, et al. A biologically active constituent of withania somnifera (ashwagandha) with antistress activityIndian J Clin Biochem. (2001)
  155. ^ Bredt DS, et al. Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphoraseNeuron. (1991)
  156. ^ Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues.
  157. a b c d Bhattacharya SK, Muruganandam AV. Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stressPharmacol Biochem Behav. (2003)
  158. a b c d Gupta GL, Rana AC. Protective effect of Withania somnifera dunal root extract against protracted social isolation induced behavior in ratsIndian J Physiol Pharmacol. (2007)
  159. ^ Goldberg DP, Hillier VF. A scaled version of the General Health QuestionnairePsychol Med. (1979)
  160. a b c Biswal BM, et al. Effect of Withania somnifera (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patientsIntegr Cancer Ther. (2013)
  161. ^ Gupta GL, Rana AC. Effect of Withania somnifera Dunal in ethanol-induced anxiolysis and withdrawal anxiety in ratsIndian J Exp Biol. (2008)
  162. a b A standardized Withania somnifera extract significantly reduces stress-related parameters in chronically stressed humans: a double-blind, randomized, placebo-controlled study.
  163. ^ Cooley K, et al. Naturopathic care for anxiety: a randomized controlled trial ISRCTN78958974PLoS One. (2009)
  164. ^ Andrade C, et al. A double-blind, placebo-controlled evaluation of the anxiolytic efficacy ff an ethanolic extract of withania somniferaIndian J Psychiatry. (2000)
  165. a b Maity T, et al. A study on evalution of antidepressant effect of imipramine adjunct with Aswagandha and BramhiNepal Med Coll J. (2011)
  166. ^ Gautam A, Wadhwa R, Thakur MK. Involvement of hippocampal Arc in amnesia and its recovery by alcoholic extract of Ashwagandha leavesNeurobiol Learn Mem. (2013)
  167. ^ Ahmed ME, et al. Attenuation of oxidative damage-associated cognitive decline by Withania somnifera in rat model of streptozotocin-induced cognitive impairmentProtoplasma. (2013)
  168. ^ Plaschke K, et al. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing miceJ Alzheimers Dis. (2010)
  169. ^ Jain S, et al. Neuroprotective effects of Withania somnifera Dunn. in hippocampal sub-regions of female albino ratPhytother Res. (2001)
  170. a b Kumar A, Kalonia H. Protective effect of Withania somnifera Dunal on the behavioral and biochemical alterations in sleep-disturbed mice (Grid over water suspended method)Indian J Exp Biol. (2007)
  171. a b Ilayperuma I, Ratnasooriya WD, Weerasooriya TR. Effect of Withania somnifera root extract on the sexual behaviour of male ratsAsian J Androl. (2002)
  172. a b c d Kaurav BP, et al. Influence of Withania somnifera on obsessive compulsive disorder in miceAsian Pac J Trop Med. (2012)
  173. ^ Krishnamurthy MN, Telles S. Assessing depression following two ancient Indian interventions: effects of yoga and ayurveda on older adults in a residential homeJ Gerontol Nurs. (2007)
  174. ^ Manjunath NK, Telles S. Influence of Yoga and Ayurveda on self-rated sleep in a geriatric populationIndian J Med Res. (2005)
  175. a b c d e f g Raut AA, et al. Exploratory study to evaluate tolerability, safety, and activity of Ashwagandha (Withania somnifera) in healthy volunteersJ Ayurveda Integr Med. (2012)
  176. ^ Joel D. Current animal models of obsessive compulsive disorder: a critical reviewProg Neuropsychopharmacol Biol Psychiatry. (2006)
  177. ^ Evaluation of Ashwagandha in alcohol withdrawal syndrome.
  178. ^ Visavadiya NP, Narasimhacharya AV. Ameliorative effects of herbal combinations in hyperlipidemiaOxid Med Cell Longev. (2011)
  179. a b c d e f g h i Visavadiya NP, Narasimhacharya AV. Hypocholesteremic and antioxidant effects of Withania somnifera (Dunal) in hypercholesteremic ratsPhytomedicine. (2007)
  180. a b Gupta SK, et al. Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessmentMol Cell Biochem. (2004)
  181. ^ Mohanty IR, Arya DS, Gupta SK. Withania somnifera provides cardioprotection and attenuates ischemia-reperfusion induced apoptosisClin Nutr. (2008)
  182. ^ Hamza A, Amin A, Daoud S. The protective effect of a purified extract of Withania somnifera against doxorubicin-induced cardiac toxicity in ratsCell Biol Toxicol. (2008)
  183. a b c Sandhu JS, et al. Effects of Withania somnifera (Ashwagandha) and Terminalia arjuna (Arjuna) on physical performance and cardiorespiratory endurance in healthy young adultsInt J Ayurveda Res. (2010)
  184. a b Jilani K, et al. Withaferin A-stimulated Ca2+ entry, ceramide formation and suicidal death of erythrocytesToxicol In Vitro. (2013)
  185. a b c Datta A, et al. Antidiabetic and antihyperlipidemic activity of hydroalcoholic extract of Withania coagulans Dunal dried fruit in experimental rat modelsJ Ayurveda Integr Med. (2013)
  186. a b c d Agnihotri AP, et al. Effects of Withania somnifera in patients of schizophrenia: A randomized, double blind, placebo controlled pilot trial studyIndian J Pharmacol. (2013)
  187. ^ Effect of withania somnifera on levels of sex hormones in the diabetic male rats.
  188. a b Anwer T, et al. Protective effect of Withania somnifera against oxidative stress and pancreatic beta-cell damage in type 2 diabetic ratsActa Pol Pharm. (2012)
  189. a b c d e Effect of withania somnifera on levels of sex hormones in the diabetic male rats.
  190. ^ Park HJ, et al. Withaferin A induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytesBiofactors. (2008)
  191. a b c Wankhede S, et al. Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trialJ Int Soc Sports Nutr. (2015)
  192. ^ Shenoy S, et al. Effects of eight-week supplementation of Ashwagandha on cardiorespiratory endurance in elite Indian cyclistsJ Ayurveda Integr Med. (2012)
  193. ^ Giuliani N, et al. The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patientsBlood. (2007)
  194. ^ Ito Y, et al. Lactacystin, a proteasome inhibitor, enhances BMP-induced osteoblastic differentiation by increasing active SmadsBiochem Biophys Res Commun. (2011)
  195. ^ Canalis E, Economides AN, Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeletonEndocr Rev. (2003)
  196. ^ Margalit A, et al. Altered arachidonic acid metabolism in urate crystal induced inflammationInflammation. (1997)
  197. ^ Rasool M, Varalakshmi P. Suppressive effect of Withania somnifera root powder on experimental gouty arthritis: An in vivo and in vitro studyChem Biol Interact. (2006)
  198. ^ Sumantran VN, et al. The relationship between chondroprotective and antiinflammatory effects of Withania somnifera root and glucosamine sulphate on human osteoarthritic cartilage in vitroPhytother Res. (2008)
  199. ^ Sumantran VN, et al. Chondroprotective potential of root extracts of Withania somnifera in osteoarthritisJ Biosci. (2007)
  200. ^ Khanna D, et al. Natural products as a gold mine for arthritis treatmentCurr Opin Pharmacol. (2007)
  201. a b Nagareddy PR, Lakshmana M. Withania somnifera improves bone calcification in calcium-deficient ovariectomized ratsJ Pharm Pharmacol. (2006)
  202. a b Davis L, Kuttan G. Effect of Withania somnifera on cell mediated immune responses in miceJ Exp Clin Cancer Res. (2002)
  203. a b c d Kour K, et al. Restoration of stress-induced altered T cell function and corresponding cytokines patterns by Withanolide AInt Immunopharmacol. (2009)
  204. ^ Effect of Withania somnifera on Lysosomal Acid Hydrolases in Adjuvant-induced Arthritis in Rats.
  205. ^ Rasool M, Varalakshmi P. Immunomodulatory role of Withania somnifera root powder on experimental induced inflammation: An in vivo and in vitro studyVascul Pharmacol. (2006)
  206. a b c Khan B, et al. Augmentation and proliferation of T lymphocytes and Th-1 cytokines by Withania somnifera in stressed miceInt Immunopharmacol. (2006)
  207. a b c d Sinha P, Ostrand-Rosenberg S. Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extractCancer Immunol Immunother. (2013)
  208. a b Nagalakshmi ML, et al. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cellsInt Immunopharmacol. (2004)
  209. a b c d e f g h i j Malik F, et al. Immune modulation and apoptosis induction: Two sides of antitumoural activity of a standardised herbal formulation of Withania somniferaEur J Cancer. (2009)
  210. a b c d e f Bani S, et al. Selective Th1 up-regulating activity of Withania somnifera aqueous extract in an experimental system using flow cytometryJ Ethnopharmacol. (2006)
  211. a b c Gupta YK, et al. Reversal of paclitaxel induced neutropenia by Withania somnifera in miceIndian J Physiol Pharmacol. (2001)
  212. ^ Vetvicka V, Vetvickova J. Immune enhancing effects of WB365, a novel combination of Ashwagandha (Withania somnifera) and Maitake (Grifola frondosa) extractsN Am J Med Sci. (2011)
  213. a b Davis L, Kuttan G. Immunomodulatory activity of Withania somniferaJ Ethnopharmacol. (2000)
  214. ^ Nemmani KV, et al. Cell proliferation and natural killer cell activity by polyherbal formulation, Immu-21 in miceIndian J Exp Biol. (2002)
  215. a b Bhat J, et al. In vivo enhancement of natural killer cell activity through tea fortified with Ayurvedic herbsPhytother Res. (2010)
  216. ^ Mikolai J, et al. In vivo effects of Ashwagandha (Withania somnifera) extract on the activation of lymphocytesJ Altern Complement Med. (2009)
  217. a b c Mwitari PG, et al. Antimicrobial activity and probable mechanisms of action of medicinal plants of Kenya: Withania somnifera, Warbugia ugandensis, Prunus africana and Plectrunthus barbatusPLoS One. (2013)
  218. ^ Debnath PK, et al. Adjunct therapy of Ayurvedic medicine with anti tubercular drugs on the therapeutic management of pulmonary tuberculosisJ Ayurveda Integr Med. (2012)
  219. a b c d e f Ahmad MK, et al. Withania somnifera improves semen quality by regulating reproductive hormone levels and oxidative stress in seminal plasma of infertile malesFertil Steril. (2010)
  220. a b c d e f Mahdi AA, et al. Withania somnifera Improves Semen Quality in Stress-Related Male FertilityEvid Based Complement Alternat Med. (2009)
  221. a b Hahm ER, et al. Withaferin a suppresses estrogen receptor-α expression in human breast cancer cellsMol Carcinog. (2011)
  222. a b c d Panda S, Kar A. Withania somnifera and Bauhinia purpurea in the regulation of circulating thyroid hormone concentrations in female miceJ Ethnopharmacol. (1999)
  223. ^ Panda S, Kar A. Changes in thyroid hormone concentrations after administration of ashwagandha root extract to adult male miceJ Pharm Pharmacol. (1998)
  224. a b Combined Effects of Ashwagandha, Guggulu and Bauhinia Extracts in the Regulation of Thyroid Function and on Lipid Peroxidation in Mice.
  225. ^ Jatwa R, Kar A. Amelioration of metformin-induced hypothyroidism by Withania somnifera and Bauhinia purpurea extracts in Type 2 diabetic micePhytother Res. (2009)
  226. ^ van der Hooft CS, et al. Thyrotoxicosis following the use of ashwagandhaNed Tijdschr Geneeskd. (2005)
  227. ^ Kalani A, Bahtiyar G, Sacerdote A. Ashwagandha root in the treatment of non-classical adrenal hyperplasiaBMJ Case Rep. (2012)
  228. ^ Yang ES, et al. Combination of withaferin A and X-ray irradiation enhances apoptosis in U937 cellsToxicol In Vitro. (2011)
  229. a b c SoRelle JA, et al. Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantationDiabetologia. (2013)
  230. ^ Bhattacharya A, et al. Effect of Withania somnifera glycowithanolides on iron-induced hepatotoxicity in ratsPhytother Res. (2000)
  231. ^ Gagnon J, et al. Increased antigen responsiveness of naive CD8 T cells exposed to IL-7 and IL-21 is associated with decreased CD5 expressionImmunol Cell Biol. (2010)
  232. ^ Comber JD, Bamezai AK. In vitro derivation of interferon-γ producing, IL-4 and IL-7 responsive memory-like CD4(+) T cellsVaccine. (2012)
  233. a b Jeyanthi T, Subramanian P. Nephroprotective effect of Withania somnifera: a dose-dependent studyRen Fail. (2009)
  234. ^ Martín-Herrera D, et al. Diuretic activity of Withania aristata: an endemic Canary Island speciesJ Ethnopharmacol. (2007)
  235. a b Benjumea D, et al. Withanolides from Whitania aristata and their diuretic activityJ Ethnopharmacol. (2009)
  236. a b Senthilnathan P, et al. Chemotherapeutic efficacy of paclitaxel in combination with Withania somnifera on benzo(a)pyrene-induced experimental lung cancerCancer Sci. (2006)
  237. ^ Senthilnathan P, et al. Stabilization of membrane bound enzyme profiles and lipid peroxidation by Withania somnifera along with paclitaxel on benzo(a)pyrene induced experimental lung cancerMol Cell Biochem. (2006)
  238. ^ Senthilnathan P, et al. Enhancement of antitumor effect of paclitaxel in combination with immunomodulatory Withania somnifera on benzo(a)pyrene induced experimental lung cancerChem Biol Interact. (2006)
  239. ^ Walczak H, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivoNat Med. (1999)
  240. ^ Srivastava RK. Intracellular mechanisms of TRAIL and its role in cancer therapyMol Cell Biol Res Commun. (2000)
  241. ^ Ichikawa H, et al. Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-kappaB (NF-kappaB) activation and NF-kappaB-regulated gene expressionMol Cancer Ther. (2006)
  242. ^ Kim S, et al. Sanguinarine-induced apoptosis: generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAILJ Cell Biochem. (2008)
  243. a b Lee TJ, et al. Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIPFree Radic Biol Med. (2009)
  244. ^ Jung EM, et al. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5)Carcinogenesis. (2005)
  245. ^ Kim H, et al. Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5Cancer Res. (2006)
  246. ^ Roué G, et al. Selective inhibition of IkappaB kinase sensitizes mantle cell lymphoma B cells to TRAIL by decreasing cellular FLIP levelJ Immunol. (2007)
  247. a b Mohan R, et al. Withaferin A is a potent inhibitor of angiogenesisAngiogenesis. (2004)
  248. ^ Lee DH, et al. Withaferin A inhibits matrix metalloproteinase-9 activity by suppressing the Akt signaling pathwayOncol Rep. (2013)
  249. ^ Thiery JP. Epithelial-mesenchymal transitions in tumour progressionNat Rev Cancer. (2002)
  250. ^ Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transitionJ Clin Invest. (2009)
  251. a b Hahm ER, et al. Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen speciesPLoS One. (2011)
  252. ^ Hahm ER, Singh SV. Autophagy fails to alter withaferin a-mediated lethality in human breast cancer cellsCurr Cancer Drug Targets. (2013)
  253. ^ Yu H, Kortylewski M, Pardoll D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironmentNat Rev Immunol. (2007)
  254. ^ Turkson J, Jove R. STAT proteins: novel molecular targets for cancer drug discoveryOncogene. (2000)
  255. a b c d Lee J, Hahm ER, Singh SV. Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cellsCarcinogenesis. (2010)
  256. ^ Heinrich PC, et al. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathwayBiochem J. (1998)
  257. a b c Stan SD, et al. Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivoCancer Res. (2008)
  258. ^ Dijkers PF, et al. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1Curr Biol. (2000)
  259. ^ Mumm JS, Kopan R. Notch signaling: from the outside inDev Biol. (2000)
  260. ^ Reedijk M, et al. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survivalCancer Res. (2005)
  261. ^ Hu C, et al. Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumorsAm J Pathol. (2006)
  262. ^ Koduru S, et al. Notch-1 inhibition by Withaferin-A: a therapeutic target against colon carcinogenesisMol Cancer Ther. (2010)
  263. a b Lee J, Sehrawat A, Singh SV. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cellsBreast Cancer Res Treat. (2012)
  264. ^ Hahm ER, Lee J, Singh SV. Role of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cellsMol Carcinog. (2013)
  265. ^ Khazal KF, et al. Effect of an extract of Withania somnifera root on estrogen receptor-positive mammary carcinomasAnticancer Res. (2013)
  266. a b Yadav B, et al. In Vitro Anticancer Activity of the Root, Stem and Leaves of Withania Somnifera against Various Human Cancer Cell LinesIndian J Pharm Sci. (2010)
  267. ^ Choi MJ, et al. Endoplasmic reticulum stress mediates withaferin A-induced apoptosis in human renal carcinoma cellsToxicol In Vitro. (2011)
  268. a b c d e Um HJ, et al. Withaferin A inhibits JAK/STAT3 signaling and induces apoptosis of human renal carcinoma Caki cellsBiochem Biophys Res Commun. (2012)
  269. ^ Ihle JN. STATs: signal transducers and activators of transcriptionCell. (1996)
  270. ^ Groner B, Lucks P, Borghouts C. The function of Stat3 in tumor cells and their microenvironmentSemin Cell Dev Biol. (2008)
  271. ^ Kim DJ, et al. Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesisMol Carcinog. (2007)
  272. a b c Li W, Zhao Y. Withaferin A suppresses tumor promoter 12-O-tetradecanoylphorbol 13-acetate-induced decreases in isocitrate dehydrogenase 1 activity and mitochondrial function in skin epidermal JB6 cellsCancer Sci. (2013)
  273. ^ Wittwer JA, et al. Enhancing mitochondrial respiration suppresses tumor promoter TPA-induced PKM2 expression and cell transformation in skin epidermal JB6 cellsCancer Prev Res (Phila). (2011)
  274. ^ Robbins D, et al. Isocitrate dehydrogenase 1 is downregulated during early skin tumorigenesis which can be inhibited by overexpression of manganese superoxide dismutaseCancer Sci. (2012)
  275. ^ Mayola E, et al. Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2Apoptosis. (2011)
  276. ^ Abdulkarim B, et al. Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancersOncogene. (2002)
  277. ^ The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.
  278. ^ Ravizza R, et al. Role of the p53/p21 system in the response of human colon carcinoma cells to DoxorubicinBMC Cancer. (2004)
  279. ^ Chipuk JE, et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosisScience. (2004)
  280. a b Munagala R, et al. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cellsCarcinogenesis. (2011)
  281. ^ Gupta A, et al. Efficacy of Withania somnifera on seminal plasma metabolites of infertile males: A proton NMR study at 800MHzJ Ethnopharmacol. (2013)
  282. a b Shukla KK, et al. Withania somnifera improves semen quality by combating oxidative stress and cell death and improving essential metal concentrationsReprod Biomed Online. (2011)
  283. a b Mamidi P, Thakar AB. Efficacy of Ashwagandha (Withania somnifera Dunal. Linn.) in the management of psychogenic erectile dysfunctionAyu. (2011)
  284. ^ Imokawa G, Kobayasi T, Miyagishi M. Intracellular signaling mechanisms leading to synergistic effects of endothelin-1 and stem cell factor on proliferation of cultured human melanocytes. Cross-talk via trans-activation of the tyrosine kinase c-kit receptorJ Biol Chem. (2000)
  285. ^ Nakajima H, et al. Withania somnifera extract attenuates stem cell factor-stimulated pigmentation in human epidermal equivalents through interruption of ERK phosphorylation within melanocytesJ Nat Med. (2012)
  286. a b c d e f Sehgal N, et al. Withania somnifera reverses Alzheimer’s disease pathology by enhancing low-density lipoprotein receptor-related protein in liverProc Natl Acad Sci U S A. (2012)
  287. ^ Kumar S, et al. An aqueous extract of Withania somnifera root inhibits amyloid β fibril formation in vitroPhytother Res. (2012)
  288. ^ Kumar S, et al. In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cellsPhytother Res. (2010)
  289. ^ Sagare A, et al. Clearance of amyloid-beta by circulating lipoprotein receptorsNat Med. (2007)
  290. ^ Deane R, et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brainNat Med. (2003)
  291. ^ Dries DR, Yu G, Herz J. Extracting β-amyloid from Alzheimer’s diseaseProc Natl Acad Sci U S A. (2012)
  292. ^ Uversky VN. Neurotoxicant-induced animal models of Parkinson’s disease: understanding the role of rotenone, maneb and paraquat in neurodegenerationCell Tissue Res. (2004)
  293. ^ Yadav S, et al. Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson’s disease pathogenesisMol Neurobiol. (2012)
  294. ^ Prakash J, et al. Neuroprotective role of Withania somnifera root extract in maneb-paraquat induced mouse model of parkinsonismNeurochem Res. (2013)
  295. ^ Manjunath MJ, Muralidhara. Effect of Withania somnifera supplementation on rotenone-induced oxidative damage in cerebellum and striatum of the male mice brainCent Nerv Syst Agents Med Chem. (2013)
  296. ^ RajaSankar S, et al. Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson’s disease model mouseJ Ethnopharmacol. (2009)
  297. ^ Sankar SR, et al. The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: an analysis of behavioral and biochemical variablesCell Mol Biol Lett. (2007)
  298. ^ Rajasankar S, Manivasagam T, Surendran S. Ashwagandha leaf extract: a potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson’s diseaseNeurosci Lett. (2009)
  299. ^ Kumar P, Kumar A. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington’s diseaseJ Med Food. (2009)
  300. ^ Minhas U, Minz R, Bhatnagar A. Prophylactic effect of Withania somnifera on inflammation in a non-autoimmune prone murine model of lupusDrug Discov Ther. (2011)
  301. ^ Minhas U, et al. Therapeutic effect of Withania somnifera on pristane-induced model of SLEInflammopharmacology. (2012)
  302. ^ Malhotra CL, et al. Studies on Withania ashwagandha, Kaul. IV. The effect of total alkaloids on the smooth musclesIndian J Physiol Pharmacol. (1965)
  303. ^ Grandhi A, Mujumdar AM, Patwardhan B. A comparative pharmacological investigation of Ashwagandha and GinsengJ Ethnopharmacol. (1994)
  304. ^ Prabu PC, Panchapakesan S, Raj CD. Acute and sub-acute oral toxicity assessment of the hydroalcoholic extract of Withania somnifera roots in Wistar ratsPhytother Res. (2013)
  305. ^ Owais M, et al. Antibacterial efficacy of Withania somnifera (ashwagandha) an indigenous medicinal plant against experimental murine salmonellosisPhytomedicine. (2005)
  306. ^ Aphale AA, et al. Subacute toxicity study of the combination of ginseng (Panax ginseng) and ashwagandha (Withania somnifera) in rats: a safety assessmentIndian J Physiol Pharmacol. (1998)
  307. ^ Sehgal VN, Verma P, Bhattacharya SN. Fixed-drug eruption caused by ashwagandha (Withania somnifera): a widely used Ayurvedic drugSkinmed. (2012)
  308. Andallu B, Radhika B. Hypoglycemic, diuretic and hypocholesterolemic effect of winter cherry (Withania somnifera, Dunal) rootIndian J Exp Biol. (2000)
  309. Chengappa KN, et al. Randomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorderJ Clin Psychiatry. (2013)
  310. Lopresti AL, Drummond PD, Smith SJ. A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha ( Withania somnifera) in Aging, Overweight MalesAm J Mens Health. (2019)
  311. Nasimi Doost Azgomi R, et al. Comparative evaluation of the effects of Withania somnifera with pentoxifylline on the sperm parameters in idiopathic male infertility: A triple-blind randomised clinical trialAndrologia. (2018)
  312. Chengappa KNR, et al. Adjunctive Use of a Standardized Extract of Withania somnifera (Ashwagandha) to Treat Symptom Exacerbation in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled StudyJ Clin Psychiatry. (2018)
  313. Choudhary D, Bhattacharyya S, Bose S. Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive FunctionsJ Diet Suppl. (2017)
  314. Jahanbakhsh SP, et al. Evaluation of the efficacy of Withania somnifera (Ashwagandha) root extract in patients with obsessive-compulsive disorder: A randomized double-blind placebo-controlled trialComplement Ther Med. (2016)
  315. Pingali U, Pilli R, Fatima N. Effect of standardized aqueous extract of Withania somnifera on tests of cognitive and psychomotor performance in healthy human participantsPharmacognosy Res. (2014)
  316. Ambiye VR, et al. Clinical Evaluation of the Spermatogenic Activity of the Root Extract of Ashwagandha (Withania somnifera) in Oligospermic Males: A Pilot StudyEvid Based Complement Alternat Med. (2013)
  317. Choudhary D, Bhattacharyya S, Joshi K. Body Weight Management in Adults Under Chronic Stress Through Treatment With Ashwagandha Root Extract: A Double-Blind, Randomized, Placebo-Controlled TrialJ Evid Based Complementary Altern Med. (2017)
  318. Ziegenfuss TN, et al. Effects of an Aqueous Extract of Withania somnifera on Strength Training Adaptations and Recovery: The STAR TrialNutrients. (2018)
  319. Sharma AK, Basu I, Singh S. Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled TrialJ Altern Complement Med. (2018)
  320. Ramakanth GS, et al. A randomized, double blind placebo controlled study of efficacy and tolerability of Withaina somnifera extracts in knee joint painJ Ayurveda Integr Med. (2016)
  321. Choudhary B, Shetty A, Langade DG. Efficacy of Ashwagandha (Withania somnifera L. Dunal) in improving cardiorespiratory endurance in healthy athletic adultsAyu. (2015)
  322. Dongre S, Langade D, Bhattacharyya S. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Improving Sexual Function in Women: A Pilot StudyBiomed Res Int. (2015)
  323. Kuchewar VV, Borkar MA, Nisargandha MA. Evaluation of antioxidant potential of Rasayana drugs in healthy human volunteersAyu. (2014)
  324. Salve J, et al. Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical StudyCureus. (2019)
  325. Langade D, et al. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled StudyCureus. (2019)
  326. Lopresti AL, et al. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled studyMedicine (Baltimore). (2019)
  327. Mayor S. Testosterone may improve sexual function and mood in older men with low levelsBMJ. (2016)
  328. Zahra Kiasalari, Mohsen Khalili, Mahbobeh Aghaei. Effect of withania somnifera on levels of sex hormones in the diabetic male ratsInternational Journal of Reproductive Biomed. (2009)